Physician profile
Danielle Bayer
NPI 1003202243
$9,519.61
in general payments reported to CMS, 2019-2025
14 companies · $3,073 in 2025
The $3,073 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $3,515 · 2023: $1,320 · 2024: $1,102 · 2025: $3,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,378 · Travel and Lodging: $1,018 · Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,377.70 |
| Travel and Lodging | $1,017.59 |
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,256.42 | 2022-2025 | Triclip, Mitraclip, Xience Skypoint |
| Edwards Lifesciences Corporation | $2,007.06 | 2021-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,058.39 | 2021-2024 | Watchman Flx |
| Aop Health US, LLC | $767.00 | 2025 | Rapiblyk |
| Medtronic, INC. | $754.50 | 2022-2025 | Corevalve Evolut R, Onyx Frontier |
| Abiomed | $415.10 | 2024-2025 | Impella |
| Shockwave Medical, INC | $105.57 | 2022 | |
| Amgen INC. | $34.21 | 2022-2024 | Repatha |
| Biosense Webster, INC. | $31.85 | 2025 | Nuvision Ice Catheter |
| Novartis Pharmaceuticals Corporation | $20.55 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $18.64 | 2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $17.91 | 2025 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.45 | 2022 | |
| Bridgebio Pharma, INC. | $14.96 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.